[HTML][HTML] Translation imaging in Parkinson's disease: focus on neuroinflammation

S Belloli, M Morari, V Murtaj, S Valtorta… - Frontiers in aging …, 2020 - frontiersin.org
Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the
substantia nigra pars compacta (SNpc) and the appearance of α-synuclein insoluble …

[HTML][HTML] Ozone pollution, oxidative stress, synaptic plasticity, and neurodegeneration

PC Bello-Medina, E Rodríguez-Martínez… - Neurología (English …, 2022 - Elsevier
Introduction Overpopulation and industrial growth result in an increase in air pollution,
mainly due to suspended particulate matter and the formation of ozone. Repeated exposure …

[HTML][HTML] Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery

L Mosconi, V Berti, C Guyara-Quinn, P McHugh… - PloS one, 2017 - journals.plos.org
After advanced age, female sex is the major risk factor for Alzheimer's disease (AD). The
biological mechanisms underlying the increased AD risk in women remain largely …

Mitochondrial complex 1, sigma 1, and synaptic vesicle 2A in early drug‐naive Parkinson's disease

H Wilson, G Pagano, ER de Natale… - Movement …, 2020 - Wiley Online Library
Background Dysfunction of mitochondrial energy generation may contribute to
neurodegeneration, leading to synaptic loss in Parkinson's disease (PD). The objective of …

[HTML][HTML] Novel PET biomarkers to disentangle molecular pathways across age-related neurodegenerative diseases

H Wilson, M Politis, EA Rabiner, LT Middleton - Cells, 2020 - mdpi.com
There is a need to disentangle the etiological puzzle of age-related neurodegenerative
diseases, whose clinical phenotypes arise from known, and as yet unknown, pathways that …

[HTML][HTML] PET imaging in animal models of Parkinson's disease

R Ni - Behavioural Brain Research, 2023 - Elsevier
Alpha-synucleinopathies, such as Parkinson's disease, dementia with Lewy bodies and
multiple system atrophy, are characterized by aberrant accumulation of alpha-synuclein and …

[HTML][HTML] Selecting the Best Animal Model of Parkinson's Disease for Your Research Purpose: Insight from in vivo PET Imaging Studies

CC Real, KH Binda, MB Thomsen… - Current …, 2023 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is a debilitating neurodegenerative multisystem disorder leading
to motor and non-motor symptoms in millions of individuals. Despite intense research, there …

[HTML][HTML] Automated Synthesis of 18F-BCPP-EF {2-tert-Butyl-4-Chloro-5-{6-[2-(2[18F]fluoroethoxy)-Ethoxy]-Pyridin-3-ylmethoxy}-2H-Pyridazin-3-One for Imaging of …

T Kaur, AF Brooks, KM Liddell, BD Henderson… - Frontiers in …, 2022 - frontiersin.org
Mitochondrial complex I (MC-I) is an essential component of brain bioenergetics and can be
quantified and studied using positron emission tomography (PET). A specific high affinity …

Cortical serotonergic and catecholaminergic denervation in MPTP-treated parkinsonian monkeys

GJ Masilamoni, A Weinkle, SM Papa, Y Smith - Cerebral cortex, 2022 - academic.oup.com
Decreased cortical serotonergic and catecholaminergic innervation of the frontal cortex has
been reported at early stages of Parkinson's disease (PD). However, the limited availability …

Animal model of Parkinson disease: Neuroinflammation and apoptosis in the 6-hydroxydopamine-induced model

D Hernandez-Baltazar, R Nadella… - … Animal Models of …, 2018 - books.google.com
Hydroxydopamine (6-OHDA), a synthetic neurotoxin, has been used to generate animal
models of Parkinson's disease (PD). Even though 6-OHDA induced neurodegenerative …